← Back to Clinical Trials
Recruiting NCT07527364

NCT07527364 Evaluation of Changing the Scripts Intervention in Nigeria

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07527364
Status Recruiting
Phase
Sponsor University of California, San Diego
Condition Unintended Pregnancy Prevention
Study Type INTERVENTIONAL
Enrollment 4,000 participants
Start Date 2026-04-13
Primary Completion 2028-05-30

Eligibility & Interventions

Sex Female only
Min Age 15 Years
Max Age 44 Years
Study Type INTERVENTIONAL
Interventions
Multimedia (BBC MA) intervention: Changing the Script in NigeriaSupply-side interventions (MSI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 4,000 participants in total. It began in 2026-04-13 with a primary completion date of 2028-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Center on Gender Equity and Health is evaluating a multimedia social and behavior change (SBC) intervention in Kano and Kaduna states in Nigeria to assess its impact, cost-efficiency and how it works. The intervention, led by BBC Media Action, uses radio, TV, other media, community outreach and SBC approaches to increase women's and couples' ability to make and act on reproductive and family planning decisions. Over a three-year period (2025- 2028), we will use a mixed-methods prospective longitudinal cohort study design to meet the research objectives. This includes estimating the impact of the intervention on use and intent to use modern contraception (alone, when combined with other family planning programs, and among non-users), exploring the pathways through which the intervention increases contraceptive use, estimating the cost-efficiency of the intervention and, evaluating the sustainability of the intervention. Data will be collected from three states - Kano and Kaduna (intervention states) and Nasarawa (comparison state). Through this evaluation, we aim to contribute to the family planning and mass media SBC fields by strengthening the evidence on the impact of a multimedia SBC intervention as well as the additional impact of combining the intervention with family planning service delivery interventions.

Eligibility Criteria

Inclusion Criteria: All eligibility criteria based on self-report: * Aged 15-44 years old at baseline * Female * Sexually active (based on self-report; i.e., in union) * Able to provide informed consent * Current residence in the selected intervention or comparison area Exclusion Criteria: * Are not considered sexually active (i.e. not in union) * Are unable to provide consent * Are younger than 15 years and older than 44 years at baseline

Contact & Investigator

Central Contact

Francine E Wood, PhD, MPH

✉ fwood@health.ucsd.edu

📞 +1-424-209-9188

Principal Investigator

Erin Pearson, PhD, MPH

PRINCIPAL INVESTIGATOR

University of California, San Diego

Frequently Asked Questions

Who can join the NCT07527364 clinical trial?

This trial is open to female participants only, aged 15 Years or older, up to 44 Years, studying Unintended Pregnancy Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07527364 currently recruiting?

Yes, NCT07527364 is actively recruiting participants. Contact the research team at fwood@health.ucsd.edu for enrollment information.

Where is the NCT07527364 trial being conducted?

This trial is being conducted at Kaduna, Nigeria, Kano, Nigeria, Nasarawa, Nigeria.

Who is sponsoring the NCT07527364 clinical trial?

NCT07527364 is sponsored by University of California, San Diego. The principal investigator is Erin Pearson, PhD, MPH at University of California, San Diego. The trial plans to enroll 4,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology